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ORIGINAL ARTICLE
Genetic ablation of macrohistone H2A1 leads to increased
leanness, glucose tolerance and energy expenditure in mice
fed a high-fat diet
F Sheedfar1, M Vermeer1, V Pazienza2, J Villarroya3,4, F Rappa5, F Cappello5,6, G Mazzoccoli7, F Villarroya3, H van der Molen1,
MH Hofker1,9, DP Koonen1,9 and M Vinciguerra2,6,8,9
BACKGROUND/OBJECTIVES: In the context of obesity, epigenetic mechanisms regulate cell-speciﬁc chromatin plasticity,
perpetuating gene expression responses to nutrient excess. MacroH2A1, a variant of histone H2A, emerged as a key chromatin
regulator sensing small nutrients during cell proliferation and differentiation. Mice genetically ablated for macroH2A1 (knockout
(KO)) do not show overt phenotypes under a standard diet. Our objective was to analyse the in vivo role of macroH2A1 in response
to nutritional excess.
METHODS: Twelve-week-old whole-body macroH2A1 KO male mice were given a high-fat diet (60% energy from lard) for 12 weeks
until being killed, and examined for glucose and insulin tolerance, and for body fat composition. Energy expenditure was assessed
using metabolic cages and by measuring the expression levels of genes involved in thermogenesis in the brown adipose tissue
(BAT) or in adipogenesis in the visceral adipose tissue (VAT).
RESULTS: Under a chow diet, macroH2A1 KO mice did not differ from their wild-type (WT) littermates for body weight, and for
sensitivity to glucose or insulin. However, KO mice displayed decreased heat production (Po0.05), and enhanced total activity
during the night (Po0.01). These activities related to protection against diet-induced obesity in KO mice, which displayed
decreased body weight owing to a speciﬁc decrease in fat mass (Po0.05), increased tolerance to glucose (Po0.05), and enhanced
total activity during the day (Po0.05), compared with WT mice. KO mice displayed increased expression of thermogenic genes
(Ucp1, Po0.05; Glut4, Po0.05; Cox4, Po0.01) in BAT and a decreased expression of adipogenic genes (Pparγ, Po0.05; Fabp4,
Po0.05; Glut4, Po0.05) in VAT compared with WT mice, indicative of augmented energy expenditure.
CONCLUSIONS: Genetic eviction of macroH2A1 confers protection against diet-induced obesity and metabolic derangements
in mice. Inhibition of macroH2A1 might be a helpful strategy for epigenetic therapy of obesity.
International Journal of Obesity advance online publication, 17 June 2014; doi:10.1038/ijo.2014.91
INTRODUCTION
The current pandemic in obesity/metabolic syndrome is a risk
factor for many types of diseases, including cardio-
vascular diseases and cancer.1,2 Epigenetic mechanisms of nuclear
chromatin remodelling, such as DNA methylation, posttransla-
tional modiﬁcations of histones and incorporation of histone
variants into the chromatin, are increasingly recognized as crucial
factors in the pathophysiology of obesity and related
complications.3 In fact, metabolic alterations in peripheral tissues
are triggered at the cellular level by changes in gene transcrip-
tional patterns dependent on the degree of nuclear chromatin
compaction. The latter is regulated at several levels, allowing
transcriptional plasticity:4 one way is the replacement of canonical
histones around which DNA is wrapped (H2A, H2B, H3 and H4)
with the incorporation of histone variants. The histone variant of
H2A, known as macroH2A1, is believed to act as a strong
transcriptional modulator that can either repress transcription5,6
or activate it in response to as yet undeﬁned nutrients or growth
signals.7 The transcriptional activity of macroH2A1 has come to
take a centre stage in the plasticity of stem cell differentiation and
in the pathogenesis of many cancer types.8–11 MacroH2A1 is
composed of a domain displaying 66% homology with histone
H2A, and a domain called macro that is conserved in multiple
functionally unrelated proteins throughout the animal kingdom
and that can bind in vitro with tight afﬁnity ADP-ribose-like
metabolites produced by NAD+-dependent histone deacetylase
sirtuins or by polyADP-ribose polymerase enzymes.12,13 This
binding represents a direct molecular interaction between inter-
mediate metabolism and the chromatin, whereby a metabolite
can impinge on and tweak gene expression in vitro.14–17
1Department of Pediatrics, Section Molecular Genetics, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands; 2Gastroenterology
Unit, Department of Medical Sciences, IRCCS ‘Casa Sollievo della Sofferenza’ Hospital, San Giovanni Rotondo (FG), Italy; 3Department of Biochemistry and Molecular Biology,
Institute of Biomedicine (IBUB), University of Barcelona, Barcelona, Spain; 4CIBER Fisiopatologia de la Obesidad y Nutricion, Instituto de Salud Carlos III, Madrid, Spain;
5Department of Experimental Biomedicine and Clinical Neurosciences, Section of Human Anatomy, University of Palermo, Palermo, Italy; 6Euro-Mediterranean Institute of Science
and Technology (IEMEST), Palermo, Italy; 7Division of Internal Medicine and Chronobiology Unit, Department of Medical Sciences, IRCCS ‘Casa Sollievo della Sofferenza’ Hospital,
San Giovanni Rotondo (FG), Italy and 8Institute for Liver and Digestive Health, Division of Medicine, University College London (UCL), UCL Medical School, Royal Free Hospital,
London, UK. Correspondence: Dr M Vinciguerra, Institute for Liver and Digestive Health, Division of Medicine, University College London (UCL), UCL Medical School, Royal Free
Hospital, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK.
E-mail: m.vinciguerra@operapadrepio.it
9These authors contributed equally to this work.
Received 19 March 2014; revised 6 May 2014; accepted 15 May 2014; accepted article preview online 21 May 2014
International Journal of Obesity (2014), 1–8
© 2014 Macmillan Publishers Limited All rights reserved 0307-0565/14
www.nature.com/ijo
Interestingly, in mice models of non-alcoholic fatty liver disease
(NAFLD), a disorder that is present in 90% of obese subjects,
hepatic content of macroH2A1 is augmented.18,19 Two mice
models, knockout (KO) for macroH2A1, have been reported under
a standard diet feeding. In the ﬁrst model, generated in the pure
C57Bl/6J background, developmental changes in macroH2A1-
mediated gene regulation were observed.20,21 In the second
model, KO for macroH2A1 in a mixed background led to a variable
hepatic lipid accumulation in 50% of the females.22 Therefore,
despite compelling in vitro evidence that macroH2A1 modulates
gene expression programs involved in cell metabolism, prolifera-
tion and differentiation,9,10 its role at the organism level under
nutritional stress conditions, especially during obesity, is not
understood. In this study, we challenged macroH2A1 KO mice20,21
with an obesogenic diet for 12 weeks: we found that genetic
ablation of this histone increased leanness, glucose tolerance and




Viable and fertile macroH2A1 KO mice were kindly provided by Prof John
Pehrson (University of Pennsylvania, Philadelphia, PA, USA).20 MacroH2A1
KO mice and their littermates (wild type (WT)) were bred and all
procedures were approved by the University of Groningen Ethics
Committee for Animal Experiments, which adheres to the principles and
guidelines established by the European Convention for the Protection of
Laboratory Animals. Mice were housed in a temperature-controlled room
under a 12 h light–dark cycle with ad libitum access to water and food
(2181; RMH-B Arie Blok, Woerden, The Netherlands). At the age
of 12–14 weeks, mice were individually housed and fed a HFD composed
of 60% kcal fat from lard (D12492; Research Diets, New Brunswick, NJ, USA)
for 12 weeks until being killed.
Oral glucose tolerance test and insulin tolerance test
Mice were fasted for 6 h during the daytime, and given a glucose bolus
(2 g kg− 1 of 20% glucose solution) by oral gavage (oral glucose tolerance
test (OGTT)) or intraperitoneally (IP) injected with human recombinant
insulin (0.5 U kg− 1 body weight, Actrapid; Novo Nordisk Canada Inc.,
Mississauga, ON, Canada) (insulin tolerance test (ITT)). Blood was collected
from the tail vein and glucose levels were measured with an OneTouch
Ultra glucometer (Lifescan Benelux, Beerse, Belgium) before and 15, 30, 60,
90, 120 and 150min after the gavage/injection.
Dual-energy X-ray absorptiometry scan analysis
Fat and lean mass was determined in HF-fed mice following 11 weeks of
dietary intervention using dual-energy X-ray absorptiometry (P-DEXA;
Norland Stratec Medizintechnik GmbH, Birkenfeld, Germany). Mice were
scanned under fed conditions while anaesthetized using isoﬂurane, and
data were analysed according to the manufacturer’s instructions.
In vivo metabolic analyses
Groups of 7–8 mice per genotype on HFD were placed individually in
indirect calorimetric cages (LabMaster TSE Systems, Bad Homburg,
Germany) to enable real time and continuous monitoring of metabolic
gas exchange. Following an initial 24-h acclimatization period, mice were
monitored every 13min for 24 h for 4 consecutive days. Heat production,
food intake and total activity were analysed. The respiratory exchange ratio
(RER) = VCO2 (volume of CO2 produced)/VO2 (volume of O2 consumed) was
used to estimate the percent of carbohydrates and fat contribution to
whole-body energy metabolism of mice in vivo. Carbohydrate and fat
oxidation rates were calculated from VO2 and VCO2 according to Peronnet
and Massicotte.23 Faeces were collected and measured by scale.
Analysis of plasma parameters
Insulin was determined in the plasma from 6 h fasted mice using an
Enzyme-Linked Immunosorbent Assay Kit (Mercodia Ultrasensitive Mouse
Insulin-linked Immunosorbent Assay; Orange Medica, Tilburg, The
Netherlands). Triglycerides (TGs) and total cholesterols (TCs) were
determined by commercially available kits, according to the manufac-
turer’s instructions (TG: Hitachi; Roche, Woerden, The Netherlands; TC:
cholesterol CHOD-PAP; Roche). Roche Percimat Glycerol standard
(16658800) and Cholesterol Standard FS (DiaSys Diagnostic Systems
Gmbh, Holzheim, Germany ) was used as a reference.
Biochemical analyses of Lipids
Total lipids were extracted from the liver according to Bligh and Dyer.24
Liver and plasma lipid analysis were performed using the available reagent
kits (Tri/GB kit Roche, Roche, Mannheim, Germany) based on the
manufacturer's protocol.
Immunoblot analyses in mice
The mice were fasted for 6 h and subjected to an IP injection with saline or
human recombinant insulin (0.75 U kg − 1 body weight, Actrapid; Novo
Nordisk Canada Inc.) 15 min before being killed. Liver, adipose tissue
(interscapular or visceral) and skeletal muscle tissues were rapidly removed
and frozen in liquid nitrogen. Powdered tissue was homogenized as
described previously.25 Equal amounts of protein were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to
PVDF membrane (Amersham, Buckinghamshire, UK) and the resulting
immune complex was visualized using the Molecular Imager ChemiDoc
XRS+System (Bio-Rad, Veenendaal, The Netherlands). Antibodies against
phospho- and total AKT were purchased from Cell Signaling (Leiden, The
Netherlands). β-Actin (Sigma, Zwijndrecht, The Netherlands) was used as
loading control. Densitometry was performed using the Image Lab
Software (Bio-Rad).
Histology
Parafﬁn-embedded sections of the liver or adipose tissue (4 μm) were
processed by haematoxylin and eosin for histological evaluation, as
described previously.26,27 Diagnostic classiﬁcation of NAFLD was per-
formed by applying a semiquantitative scoring system that grouped
histological features into broad categories (steatosis, hepatocellular injury,
portal inﬂammation, ﬁbrosis and miscellaneous features).26 Adipocyte area
and perimeter were evaluated using the ImagePro Plus software (Media
Cybernetics, Inc., Bethesda, MD, USA).
Gene expression analyses
Quantitative reverse transcriptase PCR (qRT-PCR) experiments were
performed as described previously.28 After homogenization of tissue
samples in RLT buffer (Qiagen, Hilden, Germany), RNA was isolated using a
column-afﬁnity-based methodology that included on-column DNA diges-
tion (RNeasy; Qiagen). One microgram of RNA was transcribed into cDNA
using MultiScribe RT and random hexamer primers (TaqMan Reverse
Transcription Reagents; Applied Biosystems, Foster City, CA, USA). For
quantitative mRNA expression analysis, TaqMan RT-PCR was performed on
the ABI PRISM 7700HT sequence detection system (Applied Biosystems).
The TaqMan RT-PCR reactions were performed in a ﬁnal volume of 25 μl
using TaqMan Universal PCR Master Mix, No AmpErase UNG reagent and
primer pair probes speciﬁc for uncoupling protein-1 (Ucp1, Mm00494069),
ﬁbroblast growth factor-21 (Fgf21, Mm00840165), peroxisome proliferator-
activated receptor-γ (Pparγ, Mm00440945), glucose transporter-4 (Glut4,
Slc2a4, Mm00436615), cytochrome c oxidase-4 (Cox4, Mm00438289), fatty
acid-binding protein-4 (Fabp4, Mm00445880) and interleukin-6 (Il-6,
Mm0044619). Controls with no RNA, primers or RT were included in each
set of experiments. Each sample was run in duplicate, and the mean value
of the duplicate was used to calculate the mRNA levels for the genes of
interest. Values were normalized to that of the reference control (Ppia,
Mm02342430) using the comparative 2−deltaCT method, following the
manufacturer's instructions and represented as fold induction in compar-
ison with WT group.
Rhythmicity of expression of considered genes was veriﬁed using
CircaDB, a data set of time-course expression experiments from mice and
humans deposited as publicly available microarray studies and high-
lighting circadian gene expression cycles (https://www.bioinf.itmat.upenn.
edu/circa).
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Statistical analysis
Results are expressed as means± s.e.m. Comparisons between groups
were performed with the parametric Student’s t-test or the non-parametric
Mann–Whitney U-test, as appropriate, using GraphPad Prism Software
(version 5.00 for Windows, San Diego, CA, USA): a P-value ⩽ 0.05 was
considered signiﬁcant.
RESULTS
MacroH2A1 KO mice are leaner and more glucose tolerant under
a HFD
To determine the impact of histone variant macroH2A1 on
obesity-associated increase in body weight gain, WT and
macroH2A1 KO mice were fed either a chow diet or a HFD. Body
weight, when being killed, in HFD-fed mice was ~ 10% lower in
macroH2A1 KO mice compared with WT littermates (Po0.001)
(Figure 1a). Next, we used a DEXA analyser, an effective method in
characterizing fat content and body composition, to examine the
content of lean and fat masses: macroH2A1 KO displayed a
signiﬁcant lower amount of fat content compared with WT mice
(15.58 ± 0.48 vs 17.82 ± 1.23 g, Po0.05), whereas there was no
statistical signiﬁcant difference between the lean mass content in
the groups (Figures 1b and c). In 90% of cases, human obesity is
accompanied by an accumulation of lipid droplets in the hepatic
parenchyma, termed NAFLD. NAFLD affects about one-third of the
overall population, and it is a main risk factor for the development
of non-alcoholic steatohepatitis, characterized not only by
increased lipid content but also by oxidative stress, inﬂammation
and deposition of extracellular matrix.29 We thus sought to analyse
if the lipid content in the liver of macroH2A1 KO was lower than in
WT mice: surprisingly, histological analysis did not reveal evident
differences between KO and WT mice, with a comparable mixed
micro/macro centrolobular steatosis (Supplementary Figure S1A).
Consistently, steatosis grade and NAFLD Activity Score in the
centrolobular areas (zone 3 of the Rappaport’s acinus) were similar
in macroH2A1 KO and WT mice (Supplementary Figures S1B
and C), liver TG and TC content were unaltered (Supplementary
Figures S1D and E) as well as the liver weight/body weight ratios
(Supplementary Figure S1F), between the two mice cohorts.
Plasma levels of TGs and TCs were similar in the KO and WT mice
under a HFD (Figures 1d and e). However, livers of 6 out of 15 WT
mice showed increased accumulation of lymphocytes in the
periportal areas (zone 1 of the Rappaport’s acins), while this was
absent in macroH2A1 KO mice (Supplementary Figures S2A
and B), indicating the existence of periportal inﬂammation in WT
but not in macroH2A1 KO. Circulatory glucose is kept within a
tightly regulated range to provide a constant fuel supply for cell
metabolism, and obesity notoriously interferes with it, often
triggering the development of type 2 diabetes. Fasting plasma
glucose levels were markedly reduced in KO mice upon HFD
compared with WT (Po0.05) (Figure 1f). A previous report
described slight glucose intolerance in macroH2A1 KO male mice
under a chow diet, with higher concentrations of blood glucose in
intraperitoneal GTTs at all times except time point zero;20 we were
not able to reproduce these ﬁndings using an OGTT. To the
contrary, upon HFD macroH2A1 KO were largely more glucose
tolerant at all times tested, with larger differences observed at 90,
120 and 150min (Figure 2a). This was reﬂected by a ~ 20% lower
area under the curve (0–150min time points) (Figure 2b). ITT
showed insulin-mediated time-dependent decreases in glycaemia
to a similar extent in macroH2A1 KO mice vs WT littermates
(Figure 2c). To gain insight into the mechanism by which systemic
glucose tolerance is maintained in HFD-fed macroH2A1 KO mice,
we characterized insulin-induced AKT signaling in the skeletal
muscle, liver and adipose tissues under insulin-stimulated condi-
tions (0.75 U kg− 1 body weight, injected 15min before being
killed) (Figures 3a and c). Interestingly, AKT phosphorylation
(T308/S473) tended to be increased in the skeletal muscle tissues
of macroH2A1 KO mice fed a HFD compared with WT controls
(Figure 3a). This trend was absent in the liver (Figure 3b) and in
the adipose tissues (Figure 3c). Altogether these ﬁndings show
that the systemic absence of macroH2A1 confers mild protection
from HFD-induced obesity as it protects from diet-induced
weight gain. Although macroH2A1 KO are not protected against
HFD-induced NAFLD, the total absence of inﬂammatory inﬁltrates
in the periportal areas suggests that the presence of macroH2A1
gene could have a proinﬂammatory effect in the progression
of NAFLD. Regarding glucose metabolism, macroH2A1 KO mice
exhibited decreased fasted glucose plasma levels and mice
remained sensitive to a glucose challenge when fed an
obesogenic HFD.
Food intake, heat production and RER in macroH2A1 KO mice
Using metabolic cages, we ascertained if the observed difference
in body weight in macroH2A1 KO mice vs WT littermates under a
HFD could be because of decreased food intake and/or increased
heat production. As shown in Figures 4a and c, under a standard,
chow diet, macroH2A1 KO mice show a tendency towards a lower
food intake and faeces production. When fed a HFD for 12 weeks,
Figure 1. MacroH2A1 KO mice are protected against body weight
gain and obesity after HFD. (a) Total body weights were measured.
(b) Representative pictures of mice under DEXA scan. (c) Quantiﬁca-
tion of lean and fat mass as determined by DEXA scan analysis.
(d) Plasma TG and (e) plasma TC concentrations. (f) Fasted glucose
was measured before being killed. Values shown are means± s.e.m.
(n= 7–8; except body weight, n= 14–15). *Po0.05, ***Po0.001,
macroH2A1 KO vs WT.
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this trend was no more evident (Figures 4b and d). Heat
production was found slightly lower in macroH2A1 KO only
during the day (Po0.05) and under a chow diet (Figure 5a). These
differences were not anymore evident upon feeding with a HFD
(Figure 5b). The RER is the ratio between the amount of CO2
produced and O2 consumed by breathing. Measuring this ratio
can be used for estimating which fuel (carbohydrate or fat) is
being metabolized to supply the body with energy. RER was
unaltered in macroH2A1 KO compared with WT mice regardless of
the time of the day or the diet administered (chow or HFD) (data
not shown). These negative data suggest that, despite some minor
differences in food intake and heat production when fed a chow
diet, macroH2A1 KO mice fed an obesogenic HFD diet display
similar basal metabolic parameters compared with their WT
littermates.
MacroH2A1 KO mice have enhanced total activity during night
time under a chow diet, and during daytime under a HFD
Recent studies have pointed out the strong relationship between
energy homeostasis and circadian activities at the molecular,
behavioural and physiological level.30 Experiments on rodents
have shown that HFD affects total circadian activities as well as
energy metabolism,31 and alters eating behaviour. These patterns
were observed because calorie intake during inactive period
(daytime) increased when eating a HFD more than when eating a
chow diet. Here, we measured total activity of macroH2A1 KO and
WT mice under a chow diet or a HFD during daytime and night
time (12 h light/12 h dark). As shown in Figure 5c, total activity was
signiﬁcantly increased (Po0.001) in macroH2A1 KO mice under a
chow diet compared with WT littermates only during night time,
which is the active period. Under a HFD, macroH2A1 KO similarly
displayed a slightly higher level of total activity, this time observable
only during daytime, which is the inactive period. These data
suggest that (i) the systemic absence of macroH2A1 might trigger
epigenetically an increase in total activity and (ii) a shift in nocturnal
mouse activity into daytime occurs upon a HFD feeding.
Control of genes involved in energy expenditure in BAT and VAT
by macroH2A1 under a HFD
An increase in total activity is usually mirrored in an increase in
energy expenditure, which might underlie the reason of the
Figure 2. MacroH2A1 KO mice display increased sensitivity to
glucose. (a) OGTT was performed in WT and macroH2A1 KO mice
fed a HFD following a 6 h fast. (b) Area under the curve (AUC) for the
OGTT. (c) ITT performed in WT and macroH2A1 KO mice fed a HFD
following a 6 h fast. Values shown are means± s.e.m. (n= 7–8).
*Po0.05, macroH2A1 KO vs WT.
Figure 3. Increased glucose clearance is not because of enhanced
insulin sensitivity in the muscle, liver and adipose tissue. Mice were
injected with insulin (0.75 U kg− 1) 15min before being killed, after
which phosphorylation status of AKT (T308/S473) was determined
by western blot. Representative immunoblots are shown in the
(a) skeletal muscle, (b) liver and (c) adipose tissue. Immunoblots
were quantiﬁed by densitometry and normalized against
total protein levels of AKT. Actin was used as a loading control.
Data are expressed as means± s.e.m. (n= 6–7 per group). *Po0.05,
macroH2A1 KO vs WT.
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increased leanness of macroH2A1 KO mice under a HFD. Obesity is
a state of excessive accumulation of TGs in VATs because of a
prolonged positive energy balance. Adipocytes are the major
storage site for fat in the form of TGs. Histological analyses of
visceral white adipose tissues (VAT) from macroH2A1 and WT mice
fed a HFD revealed normal size and perimeter of the adipocytes
on average upon quantiﬁcation (Figures 6a and c), despite a
decreased amount of total fat mass (Figure 1). The two types
of adipose tissue, VAT and brown adipose tissue (BAT) are quite
different in their location and physiological functions. VAT is the
primary site of energy storage, whereas BAT is specialized for
energy expenditure, and it is important for regulating body
temperature: thermogenesis in BAT is fundamental to energy
balance in mice and humans.32 We sought to perform qRT-PCR
gene expression studies to obtain a snapshot of the metabolic
state of BAT and VAT in macroH2A1 KO mice fed an obesogenic
diet. We analysed a panel of genes involved in BAT-related energy
expenditure (Ucp1 and Fgf21), local inﬂammation (interleukin-6,
Il-6), mitochondrial oxidative capacity (Cox4), overall adipogenesis
(Pparγ and Fabp4) and insulin-dependent glucose uptake capacity
(Glut4). In BAT from macroH2A1 mice under a HFD, we detected a
signiﬁcant increase in Ucp1, Glut4 and Cox4 mRNA levels
compared with WT mice (Figure 6d). These changes could be
indicative of enhanced thermogenesis in BAT. In VAT the mRNA
levels of the markers of adipogenesis Pparγ, Glut4 and Fabp4 were
lower in the KO animals (Figure 6e), indicative of lowered
adipogenic process. In conclusion, these data suggest that when
fed an obesogenic HFD diet, macroH2A1 KO mice develop
enhanced thermogenic gene expression in BAT and impaired
proadipogenic gene expression in VAT.
DISCUSSION
MacroH2A1 is a variant of histone H2A whose transcriptional
activity is implicated mechanistically in vitro in hepatocyte lipid
accumulation, which accompanies 90% of the cases of obesity,
and in vivo in cell stemness and tumorigenesis.8–11,18–22
MacroH2A1 KO mice have been generated by two independent
Figure 4. Food intake and faeces production are unaltered in
macroH2A1 KO mice. Food intake was measured during in vivo
metabolic analyses in mice fed a (a) chow diet or (b) a HFD. Faeces
production were measured in mice fed a (c) chow diet or (d) a HFD.
Values shown are means± s.e.m. (n= 7–8).
Figure 5. MacroH2A1 KO mice have lower heat production but higher total activity upon HFD feeding. Indirect calorimetric cage analysis was
performed during day and night time (12-h light/12-h dark) to measure (a) heat production in mice fed a chow diet (b) and in mice fed a HFD;
(c) total activity in mice fed a chow diet and in (d) mice fed a HFD. Data are expressed as means± s.e.m. (n= 7–8). *Po0.05, **Po0.01,
macroH2A1 KO vs WT.
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groups and they both reported mild metabolic effects.20,21
To understand if macroH2A1 could have systemic effects on fat
accumulation and obesity, we challenged macroH2A1 KO mice
with a HFD. We surprisingly found that whole-body macroH2A1
KO mice take on less fat mass than their WT littermates, without
signiﬁcant variations in the lean mass. Although the ablation of
macroH2A1 did not alter HFD-induced lipid accumulation in
comparison with WT mice, histological analysis showed periportal
inﬂammation in 6 out of 15 of the WT mice analysed, while
this was completely absent in macroH2A1 KO mice. Migration
of lymphocytes towards the periportal area is very common
in NAFLD spectrum.33 During non-alcoholic steatohepatitis,
periportal inﬁltration can then extend to the all the lobules.34,35
Livers from HF-fed WT mice showed increased accumulation of
lymphocytes around the periportal areas but not the centrolobular
areas, whereas all HF-fed macroH2A1 KO mice were protected
(Supplementary Figures S1 and S2). MacroH2A1 has been reported
to modulate nuclear factor-κB activity in reconstituted
nucleosomes,36 and to regulate IL-8 production in B cells.37 The
mechanism by which the absence of macroH2A1 blocks the
formation of inﬂammatory inﬁltrates warrants further investiga-
tion. The resistance of macroH2A1 KO mice to HFD was
accompanied by decreased fasting glucose levels, an increased
tolerance for glucose by OGTT and a tendency for increased
Figure 6. Increased energy expenditure-related BAT and VAT gene expression analysis in macroH2A1 KO fed a HFD. (a) Representative pictures
from haematoxylin and eosin staining of visceral white adipose tissue (VAT) sections in WT and macroH2A1 KO mice fed with a HFD.
(b) Quantiﬁcation of VAT adipocyte area (μ2) and (c) perimeter (μ) as in (a). (d) qRT-PCR analysis of mRNA expression levels of BAT Fgf21,
Ucp1, Pparγ, Fabp4, Glut4, Cox4 and Il-6. (e) VAT mRNA expression levels of Pparγ, Fabp4, Glut4, Cox4 and Il-6. All mRNA expression data refer to
mice fed a HFD, were normalized to the WT group and expressed as means± s.e.m. (n= 14–15, except qRT-PCR, n= 7–8). *Po0.05,
** Po0.01, macroH2A1 KO vs WT.
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insulin sensitivity in the skeletal muscle, without enhanced insulin
sensitivity in the liver or skeletal muscle. Increased glucose
tolerance occurred despite the development of NAFLD in the KO
mice. Although NAFLD is a strong and independent predictor for
the development of type 2 diabetes, the link between insulin
resistance and NAFLD has not always been demonstrated
and there are a number of studies reporting dissociation of
NAFLD from insulin resistance in genetic mouse models and in
patients.38–40 Our results diverge from those of Changolkar
et al.,20,21 reporting glucose intolerance in male mice fed a chow
diet. It must be noted that we used OGTT, while this previous
report used IP GTT. OGTT represents the most physiologic route of
entry of glucose, and it has been shown to be more sensitive than
IP GTT to detect glucose tolerance;41 in addition, our mice were
fed an obesogenic HFD diet. Moreover, a functional link between
glucose intolerance and increased expression of lipogenic genes
(Lpl, Serpina7, CD36), despite the absence of steatosis, was
proposed in the liver of macroH2A1 KO mice.20,21 This is
surprising, as 80–90% of the infused glucose is uptaken by the
skeletal muscle,42 rather than the liver, consistent with the
phenotype we observed in our fat model. Food intake and heat
production tended to be lower in macroH2A1 KO fed a chow diet,
differences that were mitigated in the presence of a HFD.
Interestingly, macroH2A1 KO mice have increased total activity
and display a shift in nocturnal activity into daytime upon a HFD
feeding. HFD is known to affect total circadian activities as well as
energy expenditure,31 because calorie intake during inactive
period increased when eating HFD. This phenotype is reminiscent
of the recently proposed ‘work for food’ paradigm that occurs
in mice when reduced food intake shifts the activity phase from
night time to daytime and eventually causes nocturnal
hypothermia,43 that is, decreased heat production during night
time. Whereas food restriction and HFD are extreme nutritional
scenarios, we hypothesize that systemic genetic depletion of
macroH2A1 might lead to adaptive ﬂexibility in circadian
organization of the behavioural timing, allowing mice to exploit
the diurnal temporal niche. The functional or evolutionary
advantages of these adaptive phenomena require further study,
but establish a new unappreciated epigenetic link between
metabolism and circadian rhythms (cycles iterating with a period
of 24 ± 4 h). The biological clocks are hardwired at the cellular level
by molecular oscillators working through transcriptional/trans-
lational feedback loops operated by genes and proteins ﬂuctuat-
ing rhythmically with circadian pattern. These clocks drive the
temporal variations of expression of genes encoding proteins
involved in lipid and glucose metabolism (biosynthesis, transport,
binding and lysis).44,45 The expression of a huge number of these
genes is inﬂuenced by the presence of macroH2A1 variants17,20
and shows an evident circadian rhythmicity of variation,
with the exception of Apoa1, which is characterized by ultradian
rhythmicity (period o20 h) (Supplementary Table S1). Despite the
gross analysis of energy expenditure did not indicate major
alterations in macroH2A1 KO mice, the assessment of gene
expression in BAT revealed coordinated induction of marker genes
of enhanced mitochondrial thermogenesis and glucose consump-
tion, consistently with enhanced BAT-mediated energy expendi-
ture in these mice. The parallel reduction in the expression of
genes related to adipose accretion in VAT mirrors a scenario in
which metabolic fuel is preferentially driven to energy-consuming
processes (BAT) at the expense of fat deposition (VAT).
The reduced fat content in KO mice would be the result of such
alterations. Possibly, the mild magnitude of the process (differ-
ential accumulation of % fat in macroH2A1 KOs vs WT mice across
weeks of HF diet) explains why gross measurements of energy
expenditure did not allow detecting some minor, but persistent,
enhancement in energy expenditure as pointed out by molecular
markers in BAT. Considering that promotion of BAT-mediated
energy expenditure is emerging as a potential strategy for
protection against obesity and metabolic alterations (hyper-
glycaemia, hyperlipidaemia), current data indicate macroH2A1
inhibition as a strategy worth to explore. In this respect, functional
partners of the macroH2A1 transcriptional complexes in the
adipose tissue are unknown. In cancer cells, macroH2A1 recruits to
the promoters of its target genes PELP1, a strong potentiator
of retinoid X receptor activation.46,47 In the adipose tissue, retinoid
X receptor activation is crucial for reprogramming towards energy
storage or thermogenesis.48,49 Moreover, adipose tissue is at the
nexus of mechanisms involved in lifespan and age-related
metabolic dysfunction.50 Obesity is associated with accelerated
onset of diseases common in old age, and macroH2A1 is also a
major driver in the formation of senescent-associated hetero-
chromatin foci, one of the most prominent features of cellular
senescence.50,51 It is tempting to speculate that this epigenetic
player could be at the crossroad of metabolism, energy
expenditure and cellular aging.
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